Adam R. Kalbermatten - 17 Mar 2026 Form 4 Insider Report for KORU Medical Systems, Inc. (KRMD)

Signature
/s/ Thomas Adams - Attorney-in-Fact
Issuer symbol
KRMD
Transactions as of
17 Mar 2026
Net transactions value
$0
Form type
4
Filing time
18 Mar 2026, 16:52:45 UTC
Previous filing
11 Aug 2025

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
KALBERMATTEN ADAM R President-Chief Commercial Off C/O KORU MEDICAL SYSTEMS, INC., 100 CORPORATE DRIVE, MAHWAH /s/ Thomas Adams - Attorney-in-Fact 18 Mar 2026 0002080271

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRMD Restricted Stock Unit Award +45,098 $0.000000* 45,098 17 Mar 2026 Common Stock 45,098 Direct F1, F2
transaction KRMD Performance Stock Unit Award +45,098 $0.000000* 45,098 17 Mar 2026 Common Stock 45,098 Direct F1, F3
transaction KRMD Option to buy Common Stock Award +67,779 $0.000000* 67,779 17 Mar 2026 Common Stock 67,779 $4.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each unit represents a right to receive one share of common stock underlying the vested award on the applicable vesting date.
F2 The units comprising the award vest in equal increments on March 17, 2027 and each first, second and third anniversaries thereof (each, a vesting date).
F3 These units will vest based upon the achievement of certain performance conditions as of December 31, 2028. The amount reported represents the amount of shares payable at target performance; the Reporting Person could earn 0%-150% of the amount reported depending on the level of performance achieved. These units will vest at 100% of the amount reported upon a change in control of the Company prior to December 31, 2028.

Remarks:

The filing of this statement shall not be construed as an admission (a) that the person filing this statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this statement, or (b) that this statement is legally required to be filed by such person. Power of Attorney has been previously filed.